Halozyme Therapeutics, Inc. (HALO)

61.90 -0.75 (-1.20%) USD  |  NASDAQ  |  Dec 11, 16:00
61.60 -0.30 (-0.48%) After-Hours: 07:40
More

Halozyme Therapeutics Total Operating Expenses (Quarterly)

Total Operating Expenses (Quarterly) Chart

View Total Operating Expenses (Quarterly) for HALO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Operating Expenses (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Operating Expenses (Quarterly) Range, Past 5 Years

View Total Operating Expenses (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Operating Expenses (Quarterly) Benchmarks

View Total Operating Expenses (Quarterly) Benchmarks
Start Trial
Merck & Co., Inc. Upgrade
ANI Pharmaceuticals, Inc. Upgrade
Bristol Myers Squibb Co. Upgrade
Twist Bioscience Corp. Upgrade
Aurinia Pharmaceuticals, Inc. Upgrade